Natural Language Processing and Quality Assessment in Primary Care
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The investigators propose to use a Natural Language Processing System (NLP) to provide an initial baseline report for primary care patients at risk for diabetes and cardiovascular complications that will include: a) evidence of foot exam documentation in the previous year; b) use of aspirin for cardiovascular risk reduction; and c) tobacco use. As part of a randomized trial, we plan to use a previously validated mailed survey (NCQA Provider Recognition Program) that requests information on the last foot exam, use of aspirin and tobacco. Patients who have been identified by NLP as not having had a foot exam will be randomized into treatment and control arms. Both arms will receive an informational letter; with a second mailing to nonresponders after one month, describing the key strategies for effective patient-physician communication during the clinical encounter. The treatment arm will also receive an informational letter and patient education brochure containing key messages about the importance of regular foot examinations. NLP will be repeated after 6 months to compare the impact of the patient education materials.
| Condition | Intervention |
|---|---|
|
Diabetes |
Other: Brochure: Care of the Feet for Those at Risk Other: Quality Survey: foot exam, tobacco and aspirin use |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Single Group Assignment Masking: Single Blind (Caregiver) Primary Purpose: Health Services Research |
| Official Title: | Novel Use of Natural Language Processing and Targeted Patient Education Information Regarding the Process for Completion of the Foot Examination in Primary Care |
- Completion of foot exam [ Time Frame: 6 months post intervention ] [ Designated as safety issue: No ]
- Patient report in validation of Natural Language Processing [ Time Frame: 6 months ] [ Designated as safety issue: No ]
| Enrollment: | 389 |
| Study Start Date: | January 2010 |
| Study Completion Date: | April 2011 |
| Primary Completion Date: | April 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Placebo Comparator: 1 CAre of the Feet for Those at Risk
secular trends for physician documentation in the medical record for care of the feet for high risk patients
|
Other: Brochure: Care of the Feet for Those at Risk
Patient education materials and key messages for care of the feet for those patients at risk
Other Name: Care of the Feet For Those at Risk
Other: Quality Survey: foot exam, tobacco and aspirin use
NCQA Patient Survey
Other Name: Care of the Feet For Those at Risk
|
|
Active Comparator: Care of the feet for those at risk
the impact of 1) patient survey regarding last foot exam, tobacco and aspirin use on documentation of foot exam and 2) patient education material: Care of the Foot For Those at Risk, on documentation of foot examination in the medical record
|
Other: Quality Survey: foot exam, tobacco and aspirin use
NCQA Patient Survey
Other Name: Care of the Feet For Those at Risk
|
|
Active Comparator: Impact of Quality Survey
Impact of patient survey regarding last foot exam, tobacco and aspirin use on documentation of foot exam in the medical record
|
Other: Brochure: Care of the Feet for Those at Risk
Patient education materials and key messages for care of the feet for those patients at risk
Other Name: Care of the Feet For Those at Risk
|
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- primary care patients with diagnosis of diabetes
Exclusion Criteria:
- unwilling to give informed consent
Contacts and Locations| United States, Minnesota | |
| Mayo Clinic Rochester | |
| Rochester, Minnesota, United States, 55905 | |
| Principal Investigator: | Gregory a Bartel, MD | Mayo Clinic |
| Principal Investigator: | Steven A Smith, MD | Mayo Clinic |
More Information
Additional Information:
Publications:
| Responsible Party: | Steven A. Smith M.D., Mayo Clinic |
| ClinicalTrials.gov Identifier: | NCT01023243 History of Changes |
| Other Study ID Numbers: | 08-002255 |
| Study First Received: | December 9, 2008 |
| Last Updated: | December 20, 2011 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Mayo Clinic:
|
foot exam health services practice improvement |
quality preventive services Natural Language Processing |
Additional relevant MeSH terms:
|
Aspirin Anti-Inflammatory Agents, Non-Steroidal Analgesics, Non-Narcotic Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs Pharmacologic Actions Anti-Inflammatory Agents Therapeutic Uses Antirheumatic Agents |
Fibrinolytic Agents Fibrin Modulating Agents Molecular Mechanisms of Pharmacological Action Cardiovascular Agents Hematologic Agents Platelet Aggregation Inhibitors Cyclooxygenase Inhibitors Enzyme Inhibitors Antipyretics Central Nervous System Agents |
ClinicalTrials.gov processed this record on June 18, 2013